49 Firmen

Artha AG

https://artha-x.com  

8952 Schlieren, Wagistrasse 21


 contact@artha-x.com

As a team of experienced phycisists and software engineers, we aim to provide integrated solutions harnessing the potential of seamless software-hardware integration into systems where they can be applied in a product to gain the best access to information. This data is then visualized for best use and customer benefit.

Artha AG

Wagistrasse 21

8952 Schlieren

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

BiognoSYS AG

http://www.biognosys.ch/  

8952 Schlieren, Wagistrasse 25

 +41 44 738 20 40
 info@biognosys.ch

BiognoSYS provides proteomics solutions to scientists and clinicians.

BiognoSYS AG

Wagistrasse 25

8952 Schlieren

CDR-Life AG

http://cdr-life.com/  

8952 Schlieren, Wagistrasse 14


 konstantin.vonschulthess@cdr-life.com

CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.

CDR-Life AG

Wagistrasse 14

8952 Schlieren

Cell Medica Switzerland AG

https://cellmedica.co.uk/  

8952 Schlieren, Wagistrasse 27

 +41-44-730 5180
 japar.shamshiev@cellmedica.co.uk

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

Cell Medica Switzerland AG

Wagistrasse 27

8952 Schlieren

Covagen AG

http://www.covagen.com  

8952 Schlieren, Wagistrasse 25

 +41 44 732 46 60
 info@covagen.com

Covagen develops bispecific FynomAbs by fusing its human Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action and enhanced efficacy in the treatment of inflammatory diseases and cancer.

Covagen AG

Wagistrasse 25

8952 Schlieren

Crystallise! AG

http://www.crystallise.ch  

8952 Schlieren, Grabenstrasse 11a

 +41 44 558 34 00
 info@crystallise.ch

Crystallise! operates an independent lab for crystallographic services (X-ray diffraction of single crystals) focussing on identifications of small molecule substances including air/moisture/temperature sensitive compounds and unique analyses of liquids.

Crystallise! AG

Grabenstrasse 11a

8952 Schlieren

CUTISS AG

http://cutiss.swiss  

8952 Schlieren, Wagistrasse 27

 +41 43 549 21 12
 info@cutiss.swiss

After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.

CUTISS AG

Wagistrasse 27

8952 Schlieren

Degradable Solutions AG

http://www.degradablesolutions.com/  

8952 Schlieren, Wagistrasse 23

 +41 43 433 62 00
 info.ds@ch.sunstar.com

Our objective and commitment is to develop innovative medical therapies by using degradable solutions.

Degradable Solutions AG

Wagistrasse 23

8952 Schlieren

Dualsystems Biotech AG

http://www.dualsystems.com  

8952 Schlieren, Grabenstrasse 11a

 +41 44 738 50 00
 info@dualsystems.com

Dualsystems Biotech is a provider of proteomics services for industry and academia.

Dualsystems Biotech AG

Grabenstrasse 11a

8952 Schlieren

Mehr Ergebnisse

Nach oben